Reports filed under Longevity, newest first.
The thread discusses red flags associated with the hype around experimental peptides, highlighting concerns about unproven drugs and the importance of evidence-based approaches in health and longevity discussions.
The thread discusses reports from pharmaceutical companies Eli Lilly and Novo Nordisk regarding GLP-1 weight-loss drugs. The reports suggest that these medications may have the potential to slow biological aging in patients.
The thread shares a Scientific American article discussing the use of growth hormone peptides as a potential treatment to stall the aging process. It highlights the scientific uncertainty surrounding the efficacy and safety of these peptide…